CA2159609C - Facteur xiii pour le traitement des plaies de la peau - Google Patents

Facteur xiii pour le traitement des plaies de la peau Download PDF

Info

Publication number
CA2159609C
CA2159609C CA002159609A CA2159609A CA2159609C CA 2159609 C CA2159609 C CA 2159609C CA 002159609 A CA002159609 A CA 002159609A CA 2159609 A CA2159609 A CA 2159609A CA 2159609 C CA2159609 C CA 2159609C
Authority
CA
Canada
Prior art keywords
factor xiii
preparation
skin
treatment
xiii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002159609A
Other languages
English (en)
Other versions
CA2159609A1 (fr
Inventor
Naoko Kato
Takashi Ogawa
Shuji Kondo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan Ltd filed Critical Hoechst Japan Ltd
Priority claimed from PCT/IB1994/000040 external-priority patent/WO1994022470A1/fr
Publication of CA2159609A1 publication Critical patent/CA2159609A1/fr
Application granted granted Critical
Publication of CA2159609C publication Critical patent/CA2159609C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002159609A 1993-03-30 1994-03-02 Facteur xiii pour le traitement des plaies de la peau Expired - Fee Related CA2159609C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5/71395 1993-03-30
JP7139593 1993-03-30
PCT/IB1994/000040 WO1994022470A1 (fr) 1993-03-30 1994-03-02 Facteur xiii pour le traitement des lesions cutanees

Publications (2)

Publication Number Publication Date
CA2159609A1 CA2159609A1 (fr) 1994-10-13
CA2159609C true CA2159609C (fr) 2007-10-16

Family

ID=38608929

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002159609A Expired - Fee Related CA2159609C (fr) 1993-03-30 1994-03-02 Facteur xiii pour le traitement des plaies de la peau

Country Status (1)

Country Link
CA (1) CA2159609C (fr)

Also Published As

Publication number Publication date
CA2159609A1 (fr) 1994-10-13

Similar Documents

Publication Publication Date Title
US5854403A (en) Method for isolation of highly pure von Willebrand Factor
JP3054150B2 (ja) トロンビンから誘導されたポリペプチド、組成物およびその使用方法
EP0315968B1 (fr) Formulations de protéines recombinantes ou provenant du plasma dans un milieu de basse force ionique
US5099003A (en) Method of preparing a sterile plasma-protein solution containing fibrinogen and factor xiii
Edwards et al. Tri (n-butyl) phosphate/detergent treatment of licensed therapeutic and experimental blood derivatives
JP2544968B2 (ja) 高イオン性濃度媒体中の血漿及び組換え蛋白処方物
JPH09110715A (ja) 血液凝固疾患を治療するための医薬組成物とその製造法
EP0632055B1 (fr) Substance anticoagulante obtenue de l'urine
US5202117A (en) Method of treating thrombi with g-csf
CA2052809A1 (fr) Procede de fabrication de preparations a base d'immunoglobulines a secretoires
JPH08504407A (ja) ウイルス的に安全な生物学的組成物の調製方法
JPH01250399A (ja) トリグラミン、血小板凝集抑制性ポリペプチド
KR0137476B1 (ko) 조산아의뇌실내출혈방지용치료제
EP0573605B1 (fr) Preparation de facteur ix
AU722743B2 (en) Stabilized aqueous liquid preparations of blood coagulation factor XIII
AU674061B2 (en) Factor XIII for treatment of skin wounds
CA2159609C (fr) Facteur xiii pour le traitement des plaies de la peau
JPH06135851A (ja) コンドロイチナーゼ組成物およびそれを含有する注射用製剤
JP3769035B2 (ja) 皮膚創傷治療用外用剤
JP2916947B2 (ja) Ｃｐｂ―ｉの安定化方法及び製剤組成物
US5164373A (en) Therapeutic agent for diabetic gangrene comprising factor XIII
EP1057490A2 (fr) Utilisation de l'acide tranexemique dans la préparation d'une composition de fibrinogène humain
FI109766B (fi) Menetelmä eskaraasia sisältävän proteolyyttisen seoksen valmistamiseksi
EP4387993A1 (fr) Traitement thermique à sec du facteur viii dérivé du plasma
MXPA00004085A (en) Use of tranexamic acid for the preparation of a human fibrinogen composition

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130304